Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OTIC

Otonomy (OTIC)

Otonomy Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OTIC
DateTimeSourceHeadlineSymbolCompany
04/20/20216:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
04/20/20216:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
04/20/20216:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
04/19/20217:30AMGlobeNewswire Inc.Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:OTICOtonomy Inc
04/07/202110:02PMGlobeNewswire Inc.Otonomy Announces Pricing of $30.1 Million Public OfferingNASDAQ:OTICOtonomy Inc
04/07/20214:06PMGlobeNewswire Inc.Otonomy Announces Proposed Public OfferingNASDAQ:OTICOtonomy Inc
04/07/20214:02PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OTICOtonomy Inc
04/06/20217:30AMGlobeNewswire Inc.Otonomy to Present at the Needham Virtual Healthcare ConferenceNASDAQ:OTICOtonomy Inc
04/05/20217:30AMGlobeNewswire Inc.Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual MeetingNASDAQ:OTICOtonomy Inc
03/25/20217:30AMGlobeNewswire Inc.Otonomy Initiates Phase 2 Clinical Trial of OTO-313 in TinnitusNASDAQ:OTICOtonomy Inc
02/25/20217:30AMGlobeNewswire Inc.Otonomy to Participate in Three Upcoming Investor ConferencesNASDAQ:OTICOtonomy Inc
02/22/20217:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
02/22/20217:00AMGlobeNewswire Inc.Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's DiseaseNASDAQ:OTICOtonomy Inc
02/17/20217:30AMGlobeNewswire Inc.Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual MeetingNASDAQ:OTICOtonomy Inc
02/16/20215:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTICOtonomy Inc
02/16/20213:30PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
02/16/20212:42PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
02/12/20215:50PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTICOtonomy Inc
02/12/20215:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
02/11/20214:19PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:OTICOtonomy Inc
02/11/20214:16PMGlobeNewswire Inc.Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
02/11/20214:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
02/10/202112:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
02/04/20217:30AMGlobeNewswire Inc.Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
01/20/20216:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
01/20/20216:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
01/20/20216:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
01/05/20217:30AMGlobeNewswire Inc.Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual ConferenceNASDAQ:OTICOtonomy Inc
12/17/20207:00AMGlobeNewswire Inc.Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
11/30/20207:30AMGlobeNewswire Inc.Otonomy Provides Update on OTIVIDEX® and OTO-313 ProgramsNASDAQ:OTICOtonomy Inc
 Showing the most relevant articles for your search:NASDAQ:OTIC